16th Aug 2022 12:00
Convatec Group PLC (CTEC) Convatec Group PLC: Director/PDMR Shareholding 16-Aug-2022 / 12:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. 16 August 2022 Convatec Group Plc The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares"). On 15 August 2022, Sten Scheibye, Non-Executive Director and PDMR, purchased 20,000 Shares at £2.37 per Share. Sten Scheibye’s resulting shareholding is 45,000 Shares. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Enquiries Analysts and Investors Kate Postans, VP Investor Relations, Convatec +44 (0)782 644 7807
Media Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000 Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92
About Convatec Pioneering trusted medical solutions to improve the lives we touch: Convatec is a FTSE 250 global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Group revenues in 2021 were over $2 billion. With around 10,000 colleagues, we provide our products and services in over 100 countries, united by a promise to be forever caring. Our products provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. To learn more about Convatec, please visit http://www.convatecgroup.com
|
ISIN: | GB00BD3VFW73 |
Category Code: | DSH |
TIDM: | CTEC |
LEI Code: | 213800LS272L4FIDOH92 |
Sequence No.: | 181761 |
EQS News ID: | 1421629 |
End of Announcement | EQS News Service |
Related Shares:
ConvaTec